Cargando…
Clinical efficacy and Long-term Immunogenicity of early triple dose COVID-19 mRNA vaccine in cancer patients
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Ltd.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941290/ http://dx.doi.org/10.1016/j.ejso.2022.11.202 |
| _version_ | 1784891256110841856 |
|---|---|
| author | Li, Jiaqi Lee, Matilda Peng, Siyu Yan Bin Lee, Ainsley Ryan Kiat Tay, Ryan Yong Chee, Cheng Ean Ho, Carol LF. Walsh, John Robert Chan, Yiong Huak Tan, Kelvin Bryan Lee, Soo-Chin Ann Chai, Louis Yi Sundar, Raghav |
| author_facet | Li, Jiaqi Lee, Matilda Peng, Siyu Yan Bin Lee, Ainsley Ryan Kiat Tay, Ryan Yong Chee, Cheng Ean Ho, Carol LF. Walsh, John Robert Chan, Yiong Huak Tan, Kelvin Bryan Lee, Soo-Chin Ann Chai, Louis Yi Sundar, Raghav |
| author_sort | Li, Jiaqi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9941290 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99412902023-02-21 Clinical efficacy and Long-term Immunogenicity of early triple dose COVID-19 mRNA vaccine in cancer patients Li, Jiaqi Lee, Matilda Peng, Siyu Yan Bin Lee, Ainsley Ryan Kiat Tay, Ryan Yong Chee, Cheng Ean Ho, Carol LF. Walsh, John Robert Chan, Yiong Huak Tan, Kelvin Bryan Lee, Soo-Chin Ann Chai, Louis Yi Sundar, Raghav Eur J Surg Oncol Article Published by Elsevier Ltd. 2023-02 2023-02-21 /pmc/articles/PMC9941290/ http://dx.doi.org/10.1016/j.ejso.2022.11.202 Text en Copyright © 2022 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Li, Jiaqi Lee, Matilda Peng, Siyu Yan Bin Lee, Ainsley Ryan Kiat Tay, Ryan Yong Chee, Cheng Ean Ho, Carol LF. Walsh, John Robert Chan, Yiong Huak Tan, Kelvin Bryan Lee, Soo-Chin Ann Chai, Louis Yi Sundar, Raghav Clinical efficacy and Long-term Immunogenicity of early triple dose COVID-19 mRNA vaccine in cancer patients |
| title | Clinical efficacy and Long-term Immunogenicity of early triple dose COVID-19 mRNA vaccine in cancer patients |
| title_full | Clinical efficacy and Long-term Immunogenicity of early triple dose COVID-19 mRNA vaccine in cancer patients |
| title_fullStr | Clinical efficacy and Long-term Immunogenicity of early triple dose COVID-19 mRNA vaccine in cancer patients |
| title_full_unstemmed | Clinical efficacy and Long-term Immunogenicity of early triple dose COVID-19 mRNA vaccine in cancer patients |
| title_short | Clinical efficacy and Long-term Immunogenicity of early triple dose COVID-19 mRNA vaccine in cancer patients |
| title_sort | clinical efficacy and long-term immunogenicity of early triple dose covid-19 mrna vaccine in cancer patients |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941290/ http://dx.doi.org/10.1016/j.ejso.2022.11.202 |
| work_keys_str_mv | AT lijiaqi clinicalefficacyandlongtermimmunogenicityofearlytripledosecovid19mrnavaccineincancerpatients AT leematilda clinicalefficacyandlongtermimmunogenicityofearlytripledosecovid19mrnavaccineincancerpatients AT pengsiyu clinicalefficacyandlongtermimmunogenicityofearlytripledosecovid19mrnavaccineincancerpatients AT yanbinleeainsleyryan clinicalefficacyandlongtermimmunogenicityofearlytripledosecovid19mrnavaccineincancerpatients AT kiattayryanyong clinicalefficacyandlongtermimmunogenicityofearlytripledosecovid19mrnavaccineincancerpatients AT cheechengean clinicalefficacyandlongtermimmunogenicityofearlytripledosecovid19mrnavaccineincancerpatients AT hocarollf clinicalefficacyandlongtermimmunogenicityofearlytripledosecovid19mrnavaccineincancerpatients AT walshjohnrobert clinicalefficacyandlongtermimmunogenicityofearlytripledosecovid19mrnavaccineincancerpatients AT chanyionghuak clinicalefficacyandlongtermimmunogenicityofearlytripledosecovid19mrnavaccineincancerpatients AT tankelvinbryan clinicalefficacyandlongtermimmunogenicityofearlytripledosecovid19mrnavaccineincancerpatients AT leesoochin clinicalefficacyandlongtermimmunogenicityofearlytripledosecovid19mrnavaccineincancerpatients AT annchailouisyi clinicalefficacyandlongtermimmunogenicityofearlytripledosecovid19mrnavaccineincancerpatients AT sundarraghav clinicalefficacyandlongtermimmunogenicityofearlytripledosecovid19mrnavaccineincancerpatients |